Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

294 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multiple sclerosis in the Arabian Gulf countries: a consensus statement.
Bohlega S, Inshasi J, Al Tahan AR, Madani AB, Qahtani H, Rieckmann P. Bohlega S, et al. Among authors: rieckmann p. J Neurol. 2013 Dec;260(12):2959-63. doi: 10.1007/s00415-013-6876-4. Epub 2013 Mar 17. J Neurol. 2013. PMID: 23504049 Free PMC article. Review.
Functional clinical outcomes in multiple sclerosis: Current status and future prospects.
Karabudak R, Dahdaleh M, Aljumah M, Alroughani R, Alsharoqi IA, AlTahan AM, Bohlega SA, Daif A, Deleu D, Amous A, Inshasi JS, Rieckmann P, Sahraian MA, Yamout BI. Karabudak R, et al. Among authors: rieckmann p. Mult Scler Relat Disord. 2015 May;4(3):192-201. doi: 10.1016/j.msard.2015.03.004. Epub 2015 Mar 23. Mult Scler Relat Disord. 2015. PMID: 26008936 Review.
Cladribine Tablets and Relapsing-Remitting Multiple Sclerosis: A Pragmatic, Narrative Review of What Physicians Need to Know.
AlJumah M, Alkhawajah MM, Qureshi S, Al-Thubaiti I, Ayoub O, Bohlega SA, Bushnag A, Cupler E, Daif A, El Boghdady A, Hassan A, Al Malik Y, Saeedi J, Al-Shamrany F, Shosha E, Rieckmann P. AlJumah M, et al. Among authors: rieckmann p. Neurol Ther. 2020 Jun;9(1):11-23. doi: 10.1007/s40120-020-00177-5. Epub 2020 Feb 13. Neurol Ther. 2020. PMID: 32056129 Free PMC article. Review.
Expert opinion on the use of cladribine tablets in clinical practice.
Sørensen PS, Centonze D, Giovannoni G, Montalban X, Selchen D, Vermersch P, Wiendl H, Yamout B, Salloukh H, Rieckmann P. Sørensen PS, et al. Among authors: rieckmann p. Ther Adv Neurol Disord. 2020 Jun 24;13:1756286420935019. doi: 10.1177/1756286420935019. eCollection 2020. Ther Adv Neurol Disord. 2020. PMID: 32636933 Free PMC article. Review.
Patient-reported quality of life in multiple sclerosis differs between cultures and countries: a cross-sectional Austrian-German-Polish study.
Pluta-Fuerst A, Petrovic K, Berger T, Fryze W, Fuchs S, Gold R, Kozubski W, Ladurner G, Petereit H, Potemkowski A, Rieckmann P, Sailer M, Szczudlik A, Vass K, Weber T, Zakrzewska-Pniewska B, Fazekas F. Pluta-Fuerst A, et al. Among authors: rieckmann p. Mult Scler. 2011 Apr;17(4):478-86. doi: 10.1177/1352458510391341. Epub 2010 Dec 9. Mult Scler. 2011. PMID: 21148265
Cladribine tablets for relapsing-remitting multiple sclerosis: Efficacy across patient subgroups from the phase III CLARITY study.
Rammohan K, Giovannoni G, Comi G, Cook S, Rieckmann P, Soelberg Sørensen P, Vermersch P, Hamlett A, Kurukulasuriya N; CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) Study Group. Rammohan K, et al. Among authors: rieckmann p. Mult Scler Relat Disord. 2012 Jan;1(1):49-54. doi: 10.1016/j.msard.2011.08.006. Epub 2011 Sep 15. Mult Scler Relat Disord. 2012. PMID: 25876451
294 results